Cytokines IL22 and IL23 which are related to Th9/Th17/Th22/Treg targets and display profound effects on multiple inflammatory pathways in AD (34, 35) showed a similar response to GP supplementation. This evidence concerns the gene IL22 and Alzheimer disease.